Position in NVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$9,240,211
+$549,653 QoQ
Shares Held
58,960
+3.6% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#182
of 1,603 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 56%
Shared 0%
None 44%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Orion Porfolio Solutions, LLC holds $237,611,307 across 15 Drug Manufacturers - General names. NVS ranks #7 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
51,486 | $61,753,858 | |
| 2 | JNJ |
Johnson & Johnson
|
228,001 | $57,905,413 | |
| 3 | ABBV |
AbbVie Inc.
|
130,643 | $32,875,004 | |
| 4 | AZN |
Astrazeneca PLC
|
89,022 | $16,880,351 | |
| 5 | MRK |
Merck & Co., Inc.
|
119,842 | $15,399,697 | |
| 6 | PFE |
Pfizer Inc
|
419,584 | $10,103,582 | |
| 7 | NVS |
Novartis AG
This page
|
58,960 | $9,240,211 | |
| 8 | AMGN |
Amgen Inc
|
24,477 | $8,863,611 |
All Filings in NVS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,240,211 | 58,960 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $8,690,558 | 56,894 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $5,835,072 | 42,323 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $5,487,389 | 42,790 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $4,776,143 | 39,469 | Shares | Sole | 2025-08-27 | |
| 2025-03-31 | $3,865,234 | 34,672 | Shares | Sole | 2025-08-01 | |
| 2024-12-31 | $3,271,659 | 33,621 | Shares | Sole | 2025-08-01 | |
| 2024-09-30 | $3,729,293 | 32,423 | Shares | Sole | 2025-07-31 | |
| 2024-06-30 | $3,336,882 | 31,344 | Shares | Sole | 2025-07-31 | |
| 2024-03-31 | $2,840,766 | 29,368 | Shares | Sole | 2025-07-31 | |
| 2023-12-31 | $3,024,556 | 29,955 | Shares | Sole | 2025-07-31 | |
| 2023-09-30 | $3,246,176 | 31,869 | Shares | Sole | 2025-07-31 | |
| 2023-06-30 | $3,221,854 | 31,928 | Shares | Sole | 2025-07-31 | |
| 2023-03-31 | $2,653,280 | 28,840 | Shares | Sole | 2025-07-31 | |
| 2022-12-31 | $2,661,815 | 29,341 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $2,164,764 | 28,480 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $2,668,781 | 31,572 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $5,794,834 | 66,038 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $5,520,144 | 63,109 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $4,892,979 | 59,831 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $5,458,980 | 59,831 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $3,899,939 | 45,624 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $9,622,511 | 101,901 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $9,363,244 | 107,673 | Shares | Sole | 2020-12-03 | |
| No filing history on record for this holder in this stock. | ||||||